Stroma in normal and cancer wound healing
E. Hueta b c d✉, Camille Jarozc, Hoang Q. Nguyena, Yazid Belkacémia e, Alexandre DE LA TAILLEa f, Vasilis Stavrinidesb d, Hayley C. Whitakerb d
- aINSERM, U955, Equipe 7 Créteil France
- bMolecular Diagnostics and Therapeutics Group Charles Bell House Division of Surgery and Interventional Science University College London UK
- cUniversité Paris‐Est, UPEC Créteil France
- dMolecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, UK
- eAP‐HP Hôpitaux Universitaires Henri Mondor Service d'oncologie‐radiothérapie et Centre Sein Henri Mondor Créteil France
- fAP‐HP Hôpitaux Universitaires Henri Mondor Service d'urologie Créteil France
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
It is currently believed that stroma, the connective framework of biological tissues, plays a central role in normal wound healing and in cancer. In both these contexts, stromal cellular components such as activated fibroblasts interact with complex protein networks that include growth factors, structural protein or proteinases in order to initiate and sustain an extensive remodelling process. However, although this process is usually spatially and temporally self-limited, it is unregulated in the case of cancer and leads to uncontrolled cell proliferation and invasion within tissues, metastasis and therapeutic resistance. In this review, we outline the role of stroma in normal healing, cancer and post radiotherapy, with a particular focus on the crosstalk between normal or cancer cells and fibroblasts. Understanding these mechanisms is particularly important as several stromal components have been proposed as potential therapeutic targets.
TL;DRThe role of stroma is outlined, with a particular focus on the crosstalk between normal or cancer cells and fibroblasts, in normal healing, cancer and post radiotherapy. (Semantic Scholar)